Logo image of ACMR

ACM RESEARCH INC-CLASS A (ACMR) Stock Fundamental Analysis

NASDAQ:ACMR - Nasdaq - US00108J1097 - Common Stock - Currency: USD

19.36  -0.37 (-1.88%)

After market: 19.46 +0.1 (+0.52%)

Fundamental Rating

6

ACMR gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 109 industry peers in the Semiconductors & Semiconductor Equipment industry. ACMR has an average financial health and profitability rating. ACMR has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

ACMR had positive earnings in the past year.
ACMR had a positive operating cash flow in the past year.
Each year in the past 5 years ACMR has been profitable.
In the past 5 years ACMR reported 4 times negative operating cash flow.
ACMR Yearly Net Income VS EBIT VS OCF VS FCFACMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

The Return On Assets of ACMR (5.58%) is better than 65.14% of its industry peers.
ACMR has a Return On Equity of 11.46%. This is in the better half of the industry: ACMR outperforms 69.72% of its industry peers.
ACMR's Return On Invested Capital of 9.82% is fine compared to the rest of the industry. ACMR outperforms 78.90% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ACMR is below the industry average of 11.16%.
The 3 year average ROIC (7.59%) for ACMR is below the current ROIC(9.82%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.58%
ROE 11.46%
ROIC 9.82%
ROA(3y)4.65%
ROA(5y)4.61%
ROE(3y)9.12%
ROE(5y)9.25%
ROIC(3y)7.59%
ROIC(5y)6.61%
ACMR Yearly ROA, ROE, ROICACMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400 500

1.3 Margins

ACMR's Profit Margin of 13.25% is fine compared to the rest of the industry. ACMR outperforms 68.81% of its industry peers.
ACMR's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 19.31%, ACMR is in the better half of the industry, outperforming 76.15% of the companies in the same industry.
In the last couple of years the Operating Margin of ACMR has grown nicely.
ACMR's Gross Margin of 50.06% is fine compared to the rest of the industry. ACMR outperforms 65.14% of its industry peers.
In the last couple of years the Gross Margin of ACMR has remained more or less at the same level.
Industry RankSector Rank
OM 19.31%
PM (TTM) 13.25%
GM 50.06%
OM growth 3Y9.03%
OM growth 5Y3.12%
PM growth 3Y-3.07%
PM growth 5Y-5.5%
GM growth 3Y4.22%
GM growth 5Y1.2%
ACMR Yearly Profit, Operating, Gross MarginsACMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACMR is destroying value.
The number of shares outstanding for ACMR has been increased compared to 1 year ago.
The number of shares outstanding for ACMR has been increased compared to 5 years ago.
The debt/assets ratio for ACMR is higher compared to a year ago.
ACMR Yearly Shares OutstandingACMR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ACMR Yearly Total Debt VS Total AssetsACMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

ACMR has an Altman-Z score of 2.22. This is not the best score and indicates that ACMR is in the grey zone with still only limited risk for bankruptcy at the moment.
ACMR has a worse Altman-Z score (2.22) than 62.39% of its industry peers.
ACMR has a debt to FCF ratio of 2.75. This is a good value and a sign of high solvency as ACMR would need 2.75 years to pay back of all of its debts.
ACMR has a better Debt to FCF ratio (2.75) than 67.89% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that ACMR is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.15, ACMR perfoms like the industry average, outperforming 47.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 2.75
Altman-Z 2.22
ROIC/WACC0.92
WACC10.69%
ACMR Yearly LT Debt VS Equity VS FCFACMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

ACMR has a Current Ratio of 2.31. This indicates that ACMR is financially healthy and has no problem in meeting its short term obligations.
ACMR has a Current ratio of 2.31. This is in the lower half of the industry: ACMR underperforms 66.97% of its industry peers.
A Quick Ratio of 1.38 indicates that ACMR should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.38, ACMR is doing worse than 74.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 1.38
ACMR Yearly Current Assets VS Current LiabilitesACMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

8

3. Growth

3.1 Past

ACMR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.65%, which is quite impressive.
The Earnings Per Share has been growing by 42.35% on average over the past years. This is a very strong growth
Looking at the last year, ACMR shows a very strong growth in Revenue. The Revenue has grown by 40.22%.
ACMR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 48.72% yearly.
EPS 1Y (TTM)38.65%
EPS 3Y52.55%
EPS 5Y42.35%
EPS Q2Q%30.23%
Revenue 1Y (TTM)40.22%
Revenue growth 3Y44.39%
Revenue growth 5Y48.72%
Sales Q2Q%31.21%

3.2 Future

Based on estimates for the next years, ACMR will show a small growth in Earnings Per Share. The EPS will grow by 5.08% on average per year.
Based on estimates for the next years, ACMR will show a quite strong growth in Revenue. The Revenue will grow by 16.09% on average per year.
EPS Next Y2.65%
EPS Next 2Y5.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.66%
Revenue Next 2Y19.09%
Revenue Next 3Y18.8%
Revenue Next 5Y16.09%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ACMR Yearly Revenue VS EstimatesACMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
ACMR Yearly EPS VS EstimatesACMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5 2

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.57, the valuation of ACMR can be described as very reasonable.
Based on the Price/Earnings ratio, ACMR is valued cheaply inside the industry as 94.50% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of ACMR to the average of the S&P500 Index (28.29), we can say ACMR is valued rather cheaply.
A Price/Forward Earnings ratio of 8.35 indicates a reasonable valuation of ACMR.
Based on the Price/Forward Earnings ratio, ACMR is valued cheaper than 95.41% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.32, ACMR is valued rather cheaply.
Industry RankSector Rank
PE 8.57
Fwd PE 8.35
ACMR Price Earnings VS Forward Price EarningsACMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ACMR is valued cheaper than 92.66% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACMR indicates a rather cheap valuation: ACMR is cheaper than 85.32% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.38
EV/EBITDA 5.54
ACMR Per share dataACMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ACMR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.23
PEG (5Y)0.2
EPS Next 2Y5.08%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ACMR!.
Industry RankSector Rank
Dividend Yield N/A

ACM RESEARCH INC-CLASS A

NASDAQ:ACMR (4/17/2025, 8:00:43 PM)

After market: 19.46 +0.1 (+0.52%)

19.36

-0.37 (-1.88%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-26 2025-02-26/bmo
Earnings (Next)05-08 2025-05-08/bmo
Inst Owners69.68%
Inst Owner Change-1.53%
Ins Owners5.34%
Ins Owner Change4.57%
Market Cap1.22B
Analysts81.43
Price Target35.97 (85.8%)
Short Float %8.02%
Short Ratio2.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)53.84%
Min EPS beat(2)41.87%
Max EPS beat(2)65.81%
EPS beat(4)4
Avg EPS beat(4)54.23%
Min EPS beat(4)41.87%
Max EPS beat(4)65.81%
EPS beat(8)8
Avg EPS beat(8)1391.04%
EPS beat(12)11
Avg EPS beat(12)946.26%
EPS beat(16)14
Avg EPS beat(16)715.87%
Revenue beat(2)2
Avg Revenue beat(2)8.5%
Min Revenue beat(2)4.6%
Max Revenue beat(2)12.4%
Revenue beat(4)4
Avg Revenue beat(4)9.86%
Min Revenue beat(4)0.69%
Max Revenue beat(4)21.75%
Revenue beat(8)7
Avg Revenue beat(8)9.06%
Revenue beat(12)10
Avg Revenue beat(12)9.99%
Revenue beat(16)12
Avg Revenue beat(16)7.48%
PT rev (1m)-1.28%
PT rev (3m)25.93%
EPS NQ rev (1m)0%
EPS NQ rev (3m)28.24%
EPS NY rev (1m)11.1%
EPS NY rev (3m)16.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.67%
Revenue NY rev (1m)0.65%
Revenue NY rev (3m)2.64%
Valuation
Industry RankSector Rank
PE 8.57
Fwd PE 8.35
P/S 1.56
P/FCF 18.38
P/OCF 8.02
P/B 1.35
P/tB 1.36
EV/EBITDA 5.54
EPS(TTM)2.26
EY11.67%
EPS(NY)2.32
Fwd EY11.98%
FCF(TTM)1.05
FCFY5.44%
OCF(TTM)2.41
OCFY12.47%
SpS12.39
BVpS14.33
TBVpS14.27
PEG (NY)3.23
PEG (5Y)0.2
Profitability
Industry RankSector Rank
ROA 5.58%
ROE 11.46%
ROCE 12.43%
ROIC 9.82%
ROICexc 15.25%
ROICexgc 15.32%
OM 19.31%
PM (TTM) 13.25%
GM 50.06%
FCFM 8.5%
ROA(3y)4.65%
ROA(5y)4.61%
ROE(3y)9.12%
ROE(5y)9.25%
ROIC(3y)7.59%
ROIC(5y)6.61%
ROICexc(3y)11.47%
ROICexc(5y)11.39%
ROICexgc(3y)11.51%
ROICexgc(5y)11.42%
ROCE(3y)9.71%
ROCE(5y)8.55%
ROICexcg growth 3Y8.64%
ROICexcg growth 5Y4.84%
ROICexc growth 3Y8.55%
ROICexc growth 5Y4.8%
OM growth 3Y9.03%
OM growth 5Y3.12%
PM growth 3Y-3.07%
PM growth 5Y-5.5%
GM growth 3Y4.22%
GM growth 5Y1.2%
F-Score6
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 2.75
Debt/EBITDA 0.86
Cap/Depr 862.33%
Cap/Sales 10.99%
Interest Coverage 36.38
Cash Conversion 94.71%
Profit Quality 64.17%
Current Ratio 2.31
Quick Ratio 1.38
Altman-Z 2.22
F-Score6
WACC10.69%
ROIC/WACC0.92
Cap/Depr(3y)1126.77%
Cap/Depr(5y)1047%
Cap/Sales(3y)15.44%
Cap/Sales(5y)11.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.65%
EPS 3Y52.55%
EPS 5Y42.35%
EPS Q2Q%30.23%
EPS Next Y2.65%
EPS Next 2Y5.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)40.22%
Revenue growth 3Y44.39%
Revenue growth 5Y48.72%
Sales Q2Q%31.21%
Revenue Next Year22.66%
Revenue Next 2Y19.09%
Revenue Next 3Y18.8%
Revenue Next 5Y16.09%
EBIT growth 1Y57.54%
EBIT growth 3Y57.43%
EBIT growth 5Y53.36%
EBIT Next Year13.62%
EBIT Next 3Y13.48%
EBIT Next 5Y11.43%
FCF growth 1Y147.62%
FCF growth 3YN/A
FCF growth 5Y51.73%
OCF growth 1Y302.4%
OCF growth 3YN/A
OCF growth 5Y74.58%